{"id":"https://openalex.org/W2017029939","doi":"https://doi.org/10.1016/j.ejmech.2013.04.033","title":"Synthesis and pharmacological evaluation of 2-aryloxy/arylamino-5-cyanobenzenesulfonylureas as novel thromboxane A2 receptor antagonists","display_name":"Synthesis and pharmacological evaluation of 2-aryloxy/arylamino-5-cyanobenzenesulfonylureas as novel thromboxane A2 receptor antagonists","publication_year":2013,"publication_date":"2013-04-23","ids":{"openalex":"https://openalex.org/W2017029939","doi":"https://doi.org/10.1016/j.ejmech.2013.04.033","mag":"2017029939","pmid":"https://pubmed.ncbi.nlm.nih.gov/23688698"},"language":"en","primary_location":{"id":"doi:10.1016/j.ejmech.2013.04.033","doi":"https://doi.org/10.1016/j.ejmech.2013.04.033","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ejmech.2013.04.033","pdf_url":null,"source":{"id":"https://openalex.org/S4210169613","display_name":"European Journal of Medicinal Chemistry","issn_l":"0223-5234","issn":["0223-5234","1768-3254"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053365143","display_name":"Sylvie-Mireille Bambi-Nyanguile","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I157674565","display_name":"University of Li\u00e8ge","ror":"https://ror.org/00afp2z80","country_code":"BE","type":"education","lineage":["https://openalex.org/I157674565"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Sylvie-Mireille Bambi-Nyanguile","raw_affiliation_strings":["Laboratory of Medicinal Chemistry, Drug Research Center, University of Liege, 1, Avenue de l'H\u00f4pital, Sart-Tilman, B-4000 Liege, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Medicinal Chemistry, Drug Research Center, University of Liege, 1, Avenue de l'H\u00f4pital, Sart-Tilman, B-4000 Liege, Belgium","institution_ids":["https://openalex.org/I157674565"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082090154","display_name":"Julien Hanson","orcid":"https://orcid.org/0000-0001-7063-7590","observed_orcids":["https://orcid.org/0000-0001-7063-7590"]},"institutions":[{"id":"https://openalex.org/I157674565","display_name":"University of Li\u00e8ge","ror":"https://ror.org/00afp2z80","country_code":"BE","type":"education","lineage":["https://openalex.org/I157674565"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Julien Hanson","raw_affiliation_strings":["Laboratory of Medicinal Chemistry, Drug Research Center, University of Liege, 1, Avenue de l'H\u00f4pital, Sart-Tilman, B-4000 Liege, Belgium","Molecular Pharmacology, GIGA-Signal Transduction, University of Liege, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Medicinal Chemistry, Drug Research Center, University of Liege, 1, Avenue de l'H\u00f4pital, Sart-Tilman, B-4000 Liege, Belgium","institution_ids":["https://openalex.org/I157674565"]},{"raw_affiliation_string":"Molecular Pharmacology, GIGA-Signal Transduction, University of Liege, Belgium","institution_ids":["https://openalex.org/I157674565"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025895018","display_name":"Annie Ooms","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I157674565","display_name":"University of Li\u00e8ge","ror":"https://ror.org/00afp2z80","country_code":"BE","type":"education","lineage":["https://openalex.org/I157674565"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Annie Ooms","raw_affiliation_strings":["Department of Cardiovascular Research, University of Liege, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiovascular Research, University of Liege, Belgium","institution_ids":["https://openalex.org/I157674565"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083709033","display_name":"L\u00fctfiye Alpan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I149768937","display_name":"University of Namur","ror":"https://ror.org/03d1maw17","country_code":"BE","type":"education","lineage":["https://openalex.org/I149768937"]},{"id":"https://openalex.org/I4391767857","display_name":"Namur Research Institute for Life Sciences","ror":"https://ror.org/038bmak92","country_code":"BE","type":"facility","lineage":["https://openalex.org/I149768937","https://openalex.org/I4391767857"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Lutfiye Alpan","raw_affiliation_strings":["Department of Pharmacy, Namur Thrombosis and Hemostasis Center \u2013 Narilis, University of Namur, FUNDP, 61 rue de Bruxelles, B-5000 Namur, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Namur Thrombosis and Hemostasis Center \u2013 Narilis, University of Namur, FUNDP, 61 rue de Bruxelles, B-5000 Namur, Belgium","institution_ids":["https://openalex.org/I149768937","https://openalex.org/I4391767857"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107998596","display_name":"Philippe H. Kolh","orcid":"https://orcid.org/0000-0001-5464-5515","observed_orcids":["https://orcid.org/0000-0001-5464-5515"]},"institutions":[{"id":"https://openalex.org/I157674565","display_name":"University of Li\u00e8ge","ror":"https://ror.org/00afp2z80","country_code":"BE","type":"education","lineage":["https://openalex.org/I157674565"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Philippe Kolh","raw_affiliation_strings":["Department of Cardiovascular Research, University of Liege, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiovascular Research, University of Liege, Belgium","institution_ids":["https://openalex.org/I157674565"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041424887","display_name":"Jean\u2010Michel Dogn\u00e9","orcid":"https://orcid.org/0000-0003-2107-1804","observed_orcids":["https://orcid.org/0000-0003-2107-1804"]},"institutions":[{"id":"https://openalex.org/I149768937","display_name":"University of Namur","ror":"https://ror.org/03d1maw17","country_code":"BE","type":"education","lineage":["https://openalex.org/I149768937"]},{"id":"https://openalex.org/I4391767857","display_name":"Namur Research Institute for Life Sciences","ror":"https://ror.org/038bmak92","country_code":"BE","type":"facility","lineage":["https://openalex.org/I149768937","https://openalex.org/I4391767857"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Jean-Michel Dogn\u00e9","raw_affiliation_strings":["Department of Pharmacy, Namur Thrombosis and Hemostasis Center \u2013 Narilis, University of Namur, FUNDP, 61 rue de Bruxelles, B-5000 Namur, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Namur Thrombosis and Hemostasis Center \u2013 Narilis, University of Namur, FUNDP, 61 rue de Bruxelles, B-5000 Namur, Belgium","institution_ids":["https://openalex.org/I149768937","https://openalex.org/I4391767857"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5087763748","display_name":"Bernard Pirotte","orcid":"https://orcid.org/0000-0001-8251-8257","observed_orcids":["https://orcid.org/0000-0001-8251-8257"]},"institutions":[{"id":"https://openalex.org/I157674565","display_name":"University of Li\u00e8ge","ror":"https://ror.org/00afp2z80","country_code":"BE","type":"education","lineage":["https://openalex.org/I157674565"]}],"countries":["BE"],"is_corresponding":true,"raw_author_name":"Bernard Pirotte","raw_affiliation_strings":["Laboratory of Medicinal Chemistry, Drug Research Center, University of Liege, 1, Avenue de l'H\u00f4pital, Sart-Tilman, B-4000 Liege, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Medicinal Chemistry, Drug Research Center, University of Liege, 1, Avenue de l'H\u00f4pital, Sart-Tilman, B-4000 Liege, Belgium","institution_ids":["https://openalex.org/I157674565"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5087763748"],"corresponding_institution_ids":["https://openalex.org/I157674565"],"apc_list":{"value":4650,"currency":"USD","value_usd":4650},"apc_paid":null,"fwci":0.2778,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.49307586,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"65","issue":null,"first_page":"32","last_page":"40"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.6093999743461609,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.6093999743461609,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.18639999628067017,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","score":0.09969999641180038,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/thromboxane-receptor-antagonist","display_name":"thromboxane A2 receptor antagonist","score":0.9890000224113464},{"id":"https://openalex.org/keywords/receptor-selectivity","display_name":"receptor selectivity","score":0.7160000205039978},{"id":"https://openalex.org/keywords/calcium-mobilization","display_name":"calcium mobilization","score":0.9290000200271606},{"id":"https://openalex.org/keywords/platelet-aggregation","display_name":"platelet aggregation","score":0.8539999723434448},{"id":"https://openalex.org/keywords/u46619","display_name":"U46619","score":0.8920000195503235},{"id":"https://openalex.org/keywords/bioisosteric-replacement","display_name":"bioisosteric replacement","score":0.7549999952316284},{"id":"https://openalex.org/keywords/cyano-group","display_name":"cyano group","score":0.6610000133514404},{"id":"https://openalex.org/keywords/drug-synthesis","display_name":"drug synthesis","score":0.3160000145435333},{"id":"https://openalex.org/keywords/lead-compounds","display_name":"lead compounds","score":0.382999986410141}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9042950868606567},{"id":"https://openalex.org/C51603380","wikidata":"https://www.wikidata.org/wiki/Q411978","display_name":"Thromboxane receptor","level":4,"score":0.6710706949234009},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.6617192029953003},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.6598515510559082},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.6462136507034302},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5433072447776794},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.5158376097679138},{"id":"https://openalex.org/C2781024287","wikidata":"https://www.wikidata.org/wiki/Q774909","display_name":"Thromboxane A2","level":3,"score":0.5149029493331909},{"id":"https://openalex.org/C2778122271","wikidata":"https://www.wikidata.org/wiki/Q410943","display_name":"Receptor antagonist","level":4,"score":0.4925602078437805},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2724861800670624},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009570","descriptor_name":"Nitriles","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D009570","descriptor_name":"Nitriles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D009570","descriptor_name":"Nitriles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D010974","descriptor_name":"Platelet Aggregation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D010975","descriptor_name":"Platelet Aggregation Inhibitors","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D010975","descriptor_name":"Platelet Aggregation Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D010975","descriptor_name":"Platelet Aggregation Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013453","descriptor_name":"Sulfonylurea Compounds","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D013453","descriptor_name":"Sulfonylurea Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013453","descriptor_name":"Sulfonylurea Compounds","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D044244","descriptor_name":"Receptors, Thromboxane A2, Prostaglandin H2","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D057809","descriptor_name":"HEK293 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1016/j.ejmech.2013.04.033","doi":"https://doi.org/10.1016/j.ejmech.2013.04.033","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ejmech.2013.04.033","pdf_url":null,"source":{"id":"https://openalex.org/S4210169613","display_name":"European Journal of Medicinal Chemistry","issn_l":"0223-5234","issn":["0223-5234","1768-3254"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:23688698","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23688698","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of medicinal chemistry","raw_type":"Journal Article"},{"id":"pmh:oai:pure.unamur.be:openaire_cris_publications/f937e936-2ba8-419b-b63e-33978106e500","doi":null,"is_oa":false,"landing_page_url":"https://researchportal.unamur.be/en/publications/f937e936-2ba8-419b-b63e-33978106e500","pdf_url":null,"source":{"id":"https://openalex.org/S4406922457","display_name":"Repository of the University of Namur","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bambi-Nyanguile, S M, Hanson, J, Ooms, A, Alpan, L, Kolh, P, Dogn\u00e9, J-M & Pirotte, B 2013, 'Synthesis and pharmacological evaluation of 2-aryloxy/arylamino-5- cyanobenzenesulfonylureas as novel thromboxane A 2 receptor antagonists', European Journal of Medicinal Chemistry, vol. 65, pp. 32-40. https://doi.org/10.1016/j.ejmech.2013.04.033","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:orbi.ulg.ac.be:2268/152386","doi":null,"is_oa":false,"landing_page_url":"https://orbi.uliege.be/handle/2268/152386","pdf_url":null,"source":{"id":"https://openalex.org/S4306400651","display_name":"Open Repository and Bibliography (University of Li\u00e8ge)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I157674565","host_organization_name":"University of Li\u00e8ge","host_organization_lineage":["https://openalex.org/I157674565"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"European Journal of Medicinal Chemistry, 65, 32-40 (2013-07)","raw_type":"http://purl.org/coar/resource_type/c_6501"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":43,"referenced_works":["https://openalex.org/W179499432","https://openalex.org/W1487005519","https://openalex.org/W1492270522","https://openalex.org/W1588567600","https://openalex.org/W1802267091","https://openalex.org/W1973121148","https://openalex.org/W1975258609","https://openalex.org/W1993389065","https://openalex.org/W2003084614","https://openalex.org/W2005913504","https://openalex.org/W2014435551","https://openalex.org/W2019171004","https://openalex.org/W2026652904","https://openalex.org/W2026925698","https://openalex.org/W2030087792","https://openalex.org/W2030793740","https://openalex.org/W2039222897","https://openalex.org/W2048009051","https://openalex.org/W2051823344","https://openalex.org/W2052817546","https://openalex.org/W2056516712","https://openalex.org/W2058217708","https://openalex.org/W2058256167","https://openalex.org/W2078328099","https://openalex.org/W2082501322","https://openalex.org/W2085308671","https://openalex.org/W2087282099","https://openalex.org/W2092296830","https://openalex.org/W2100658366","https://openalex.org/W2109105568","https://openalex.org/W2111015948","https://openalex.org/W2114632037","https://openalex.org/W2130963215","https://openalex.org/W2146408106","https://openalex.org/W2146972322","https://openalex.org/W2147195562","https://openalex.org/W2155161187","https://openalex.org/W2161488081","https://openalex.org/W2187596630","https://openalex.org/W2240934769","https://openalex.org/W2463132395","https://openalex.org/W4406065711","https://openalex.org/W4406065720"],"related_works":["https://openalex.org/W7036963134","https://openalex.org/W2058256167","https://openalex.org/W2264382224","https://openalex.org/W2014435551","https://openalex.org/W1998036582","https://openalex.org/W2246141768","https://openalex.org/W2327205535","https://openalex.org/W2067787982","https://openalex.org/W2053514230","https://openalex.org/W2091248992"],"abstract_inverted_index":null,"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}